Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy

Trial Profile

Towards Eradication: Reducing Proviral HIV DNA With Interferon-a Immunotherapy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 15 May 2017

At a glance

  • Drugs Peginterferon alfa-2b (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms BEAT-HIV
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 May 2017 Planned End Date changed from 1 Jan 2018 to 1 Aug 2018.
    • 08 May 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Feb 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top